Remedy Entertainment, known for the likes of Alan Wake, Control, Quantum Break and more, has announced that it has entered into a global development, license and distribution agreeement with Chinese tech giant Tencent for an upcoming free-to-play co-operative PvE shooter codenamed "Vanguard".
The game is said to currently be in the proof-of-concept phase, and will "combine Remedy’s narrative expertise and action gameplay into an immersive multiplayer experience." It'll be developed using Unreal Engine, and its development budget will be "in the range of a typical Remedy AAA game budget."
So, where does Tencent come in? The plan is for Remedy to develop and publish Vanguard worldwide, however Tencent will localise and publish it for selected Asian markets. In addition, Tencent has been granted worldwide rights to develop and publish a mobile version of the game.
Here's what Tero Virtala, CEO of Remedy Entertainment, had to say about the news:
“Vanguard marks Remedy’s first entry into Games-as-a-Service business model, executed by our top tier team of free-to-play experts. We are building something new and exciting for co-operative multiplayer space, on top of Remedy’s strengths. Expanding our capabilities to take on publishing responsibilities is the next step in the development of our company.
We are excited for this long-term partnership with Tencent and with confidence can say that it is an excellent fit in supporting Vanguard’s ambitious plans. Vanguard is a global opportunity, and Tencent can support Remedy internationally, and lead the operations in Asia and the mobile markets.”
Remedy is busy with a variety of projects at the moment — there's the upcoming release of Xbox exclusive CrossfireX, a multiplayer spin-off of Control codenamed "Condor", and the highly-anticipated 2023 release of Alan Wake 2. Plus, there are preliminary plans in place for a full-blown Control sequel as well.
Sounds like the studio has got a hectic few years ahead!
What do you make of this news? Let us know down in the comments section below.